CIT Group Inc. (NYSE: CIT) is getting crushed and is back under $1.00 on its news this morning.

Goldman Sachs Group Inc. (NYSE: GS) is down almost 2% on the Meredith Whitney downgrade.

Citigroup, Inc. (NYSE: C) is up marginally despite an analyst “BUY” recommendation.

Johnson & Johnson (NYSE: JNJ) is down 2.5% at $60.95 despite beating earnings because revenues were light and ‘raised guidance’ looks effectively in-line.

Novavax, Inc. (NASDAQ: NVAX) is rising over 7% on a small NIH grant.

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is one of this morning’s top gainers on a a Novartis pact.

Vascular Solutions, Inc. (NASDAQ: VASC) is another top percentage gainer on FDA marketing approval for its next-generation Guardian II Hemostasis valve.

You can join our open email distribution list to get updates each morning on analyst upgrades and downgrades, top day trader alerts, IPO’s and secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG
OCTOBER 13, 2009